- Home
- ACHV vs YDDL Comparison
ACHV vs YDDL Comparison
Compare ACHV & YDDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACHV | YDDL |
|---|---|---|
| Founded | N/A | 2014 |
| Country | United States | Philippines |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 231.0M | 275.4M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | ACHV | YDDL |
|---|---|---|
| Price | $4.22 | $6.42 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $15.50 | N/A |
| AVG Volume (30 Days) | ★ 828.7K | 81.8K |
| Earning Date | 03-10-2026 | 02-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 310.92 |
| EPS | N/A | ★ 0.15 |
| Revenue | N/A | ★ $62,922,700.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $45.72 |
| Revenue Growth | N/A | ★ 118.15 |
| 52 Week Low | $1.84 | $3.61 |
| 52 Week High | $6.03 | $8.89 |
Technical Indicators
Market Signals| Indicator | ACHV | YDDL |
|---|---|---|
| Relative Strength Index (RSI) | 34.31 | 62.03 |
| Support Level | $4.05 | $6.00 |
| Resistance Level | $4.49 | $6.90 |
| Average True Range (ATR) | 0.34 | 0.55 |
| MACD | -0.18 | 0.03 |
| Stochastic Oscillator | 5.82 | 77.04 |
Price Performance
Historical ComparisonAbout ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About YDDL One and One Green Technologies. Inc Class A Ordinary Shares
One and one Green Technologies Inc is engaged in recycling, production, and trading of recycled scrap metals in the Republic of Philippines. The company process raw materials and generate final products that include copper alloy ingot, aluminum scrapes, plastic beads, and others. It provides economical and flexible solutions to the challenges of electronic waste, metal scrap and industrial recycling. By providing lower-cost alternatives for processing recycled materials, It is not only Contributing to environmental sustainability but also highlight its role as a modern and specialized recycling company.